Home Newsroom News First prototype of the DECIDE service

First prototype of the DECIDE service

Paris, 18 July 2011. The prototype of an SPM-BASED application to analyze FDG PET and rCBF/SPECT images on single cases has been presented to the clinical reference community as the DECIDE service for the early diagnosis of the Alzheimer.

The presentation occurred during the FP7 project DECIDE annual workshop “The assessment of imaging biomarkers for the early and differential diagnosis of Alzheimer’s disease” which was held in Paris on July18th 2011 in co-location with the ICAD 2011 (July 16-21), the world's leading forum on dementia research.


Speakers of the workshop have been Giovanni Frisoni, Neurologist and Deputy Scientific Director at IRCCS Fatebenefratelli in Brescia (DECIDE Scientific Coordinator), Daniela Perani, Neurologist, Radiologist and full Professor of Neuroscience at University Vita-Salute San Raffaele in  Milan (DECIDE Principal Investigator for University Vita-Salute San Raffaele), Isabella Castiglioni, Physicist and Researcher at CNR in Milan (DECIDE Manager of Joint Research Activities) and Laura Leone,  network senion engineer at GARR in Rome (coordinator of FP7 project DECIDE). More details on the programme are on http://www.eu-decide.eu/index.php/events/19-next-events/21-decide-annual-workshop-18-july-2011

In particular, it has been introduced to an audience of clinicians, neurologists and imaging experts, who are meant to become the service’s users,  the algorithm GriSPM, an user friendly tool to evaluate brain metabolism and  perfusion as functional biomarkers in subjects with cognitive decline and in patients with dementia.

The service is intended to support physicians in their assessment of possible and probabale AD cases, especially in early stages such as the Mild Cognitive Impairment and in case the clinical picture appears not univocal for differential diagnosis. Clinicians will need to qualify to use the service, but after that they’ll be able to run the algorithm from their laptops, through a normal web browser.

The prototype presentation has been welcomed with great enthusiasm by the reference community and an interesting debate on the development and use of the service, as well as its applications both in diagnosis and research has occurred.

Within the DECIDE project is ongoing the betatesting phase performed by experts in neuroimaging to validate the system.. Next step of the DECIDE project will be to select an external panel of experts and potential users of the early diagnosis service for its further validation and testing. Some of the workshop attendees have already expressed interest in this activity, as well as many partners of the European Alzheimer Disease Consortium (EADC) all across Europe.

The next public presentation of the service, which encompasses a suite of algorithms with research and/or diagnostic purposes, will be held during the DECIDE workshop at AE next conference in Warsaw (http://www.alzheimer-europe.org/EN/Conferences/Warsaw-2011).


See the programme


Seventh Framework Programme - Eurpean Commission

We use cookies to improve our website and your experience when using it. Cookies used for the essential operation of the site have already been set. To find out more about the cookies we use and how to delete them, see our privacy policy.

I accept cookies from this site.

EU Cookie Directive Module Information